The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome
Open accessAbstract
Background: Interleukin ( IL )‐1β, IL ‐18, and downstream IL ‐6 are key inflammatory cytokines in the pathogenesis of coronary artery disease. Colchicine is believed to block the NLRP 3 inflammasome, a cytosolic complex responsible for the production of IL ‐1β and IL ‐18. In vivo effects of colchicine on cardiac cytokine release have not been previously studied. This study aimed to (1) assess the local cardiac production of inflammatory cytokines in patients with acute coronary syndromes ( ACS ), stable coronary artery disease and in controls; and (2) determine whether acute administration of colchicine inhibits their production. Methods and Results: Forty ACS patients, 33 with stable coronary artery disease, and 10 controls, were included. ACS and stable coronary artery disease patients were randomized to oral colchicine treatment (1 mg followed by 0.5 mg 1 hour later) or no colchicine, 6 to 24 hours prior to cardiac catheterization. Blood samples from the coronary sinus, aortic root (arterial), and lower right atrium (venous) were collected and tested for IL ‐1β, IL ‐18, and IL ‐6 using ELISA . In ACS patients, coronary sinus levels of IL ‐1β, IL ‐18, and IL ‐6 were significantly higher than arterial and venous levels ( P =0.017, <0.001 and <0.001, respectively). Transcoronary (coronary sinus‐arterial) gradients for IL ‐1β, IL ‐18, and IL ‐6 were highest in ACS patients and lowest in controls ( P =0.077, 0.033, and 0.014, respectively). Colchicine administration significantly reduced transcoronary gradients of all 3 cytokines in ACS patients by 40% to 88% ( P =0.028, 0.032, and 0.032, for IL ‐1β, IL ‐18, and IL ‐6, respectively). Conclusions: ACS patients exhibit increased local cardiac production of inflammatory cytokines. Short‐term colchicine administration rapidly and significantly reduces levels of these cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gout-associated uric acid crystals activate the NALP3 inflammasome
Martinon, F., Pétrilli, V., Mayor, A., Tardivel, A., & Tschopp, J. (2006) · Nature · doi:10.1038/nature04516 · Cited by 5,326
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Inflammation in Atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.009 · Cited by 2,228
WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., Jacobs, A. K., Kern, M. J., King, S. B., Morrison, D. A., O’Neill, W. W., Schaff, H. V., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.170815 · Cited by 2,218
Ryan, T. J., Faxon, D. P., Gunnar, R. M., Kennedy, J. W., King, S. B., Loop, F. D., Peterson, K. L., Reeves, T. J., Williams, D. O., & Winters, W. L. (1988) · Circulation · doi:10.1161/01.cir.78.2.486 · Cited by 2,123
Hofstra, L., Tordoir, J. H. M., Kitslaar, P. J. E. H. M., Hoeks, A. P. G., & Daemen, M. J. A. P. (1996) · Circulation · doi:10.1161/01.cir.94.6.1283 · Cited by 1,603
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Nidorf, S. M., Eikelboom, J. W., Budgeon, C. A., & Thompson, P. L. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.027 · Cited by 1,054
Rajamäki, K., Lappalainen, J., Öörni, K., Välimäki, E., Matikainen, S., Kovanen, P. T., & Eklund, K. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011765 · Cited by 1,039
King, S. B., Smith, S. C., Hirshfeld, J. W., Jacobs, A. K., Morrison, D. A., Williams, D. O., 2005 WRITING COMMITTEE MEMBERS, Smith, S. C., Feldman, T. E., Hirshfeld, J. W., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.188208 · Cited by 1,014
Widespread Coronary Inflammation in Unstable Angina
Buffon, A., Biasucci, L. M., Liuzzo, G., D'Onofrio, G., Crea, F., & Maseri, A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012295 · Cited by 922
Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
Misawa, T., Takahama, M., Kozaki, T., Lee, H., Zou, J., Saitoh, T., & Akira, S. (2013) · Nature Immunology · doi:10.1038/ni.2550 · Cited by 855
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
A clinical perspective of IL‐1β as the gatekeeper of inflammation
Dinarello, C. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141550 · Cited by 775
Lack of Interleukin-1β Decreases the Severity of Atherosclerosis in ApoE-Deficient Mice
Kirii, H., Niwa, T., Yamada, Y., Wada, H., Saito, K., Iwakura, Y., Asano, M., Moriwaki, H., & Seishima, M. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000064374.15232.c3 · Cited by 748
Kaptoge, S., Seshasai, S. R. K., Gao, P., Freitag, D. F., Butterworth, A. S., Borglykke, A., Di Angelantonio, E., Gudnason, V., Rumley, A., Lowe, G. D. O., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht367 · Cited by 666
Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability
Mallat, Z., Corbaz, A., Scoazec, A., Besnard, S., Lesèche, G., Chvatchko, Y., & Tedgui, A. (2001) · Circulation · doi:10.1161/hc3901.096721 · Cited by 636
Self-citation2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
King, S. B., Smith, S. C., Hirshfeld, J. W., Morrison, D. A., Williams, D. O., & Jacobs, A. K. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.002 · Cited by 612
A Randomized Trial of Colchicine for Acute Pericarditis
Imazio, M., Brucato, A., Cemin, R., Ferrua, S., Maggiolini, S., Beqaraj, F., Demarie, D., Forno, D., Ferro, S., Maestroni, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208536 · Cited by 611
Interleukin-18 Is a Strong Predictor of Cardiovascular Death in Stable and Unstable Angina
Blankenberg, S., Tiret, L., Bickel, C., Peetz, D., Cambien, F., Meyer, J., & Rupprecht, H. J. (2002) · Circulation · doi:10.1161/01.cir.0000020546.30940.92 · Cited by 568
Terkeltaub, R. A., Furst, D. E., Bennett, K., Kook, K. A., Crockett, R. S., & Davis, M. W. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27327 · Cited by 536
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
Multiple Roles for Neutrophils in Atherosclerosis
Soehnlein, O. (2012) · Circulation Research · doi:10.1161/circresaha.111.257535 · Cited by 498
Fox, K. A. A., Carruthers, K. F., Dunbar, D. R., Graham, C., Manning, J. R., De Raedt, H., Buysschaert, I., Lambrechts, D., & Van de Werf, F. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq326 · Cited by 468
O’Donoghue, M. L., Braunwald, E., White, H. D., Steen, D. P., Lukas, M. A., Tarka, E., Steg, P. G., Hochman, J. S., Bode, C., Maggioni, A. P., et al. (2014) · JAMA · doi:10.1001/jama.2014.11061 · Cited by 456
Mallat, Z., Corbaz, A., Scoazec, A., Graber, P., Alouani, S., Esposito, B., Humbert, Y., Chvatchko, Y., & Tedgui, A. (2001) · Circulation Research · doi:10.1161/hh1901.098735 · Cited by 407
Self-citationInterleukin-18 Enhances Atherosclerosis in Apolipoprotein E −/− Mice Through Release of Interferon-γ
Whitman, S. C., Ravisankar, P., & Daugherty, A. (2002) · Circulation Research · doi:10.1161/hh0202.105292 · Cited by 385
Luc, G., Bard, J.-M., Juhan-Vague, I., Ferrieres, J., Evans, A., Amouyel, P., Arveiler, D., Fruchart, J.-C., & Ducimetiere, P. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000079512.66448.1d · Cited by 378
The Role of the Interleukin-1–Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1
Dinarello, C. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009073431011 · Cited by 373
Everett, B. M., Pradhan, A. D., Solomon, D. H., Paynter, N., MacFadyen, J., Zaharris, E., Gupta, M., Clearfield, M., Libby, P., Hasan, A. A. K., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.03.018 · Cited by 368 · cited 1×
“The ongoing Cardiovascular Inflammation Reduction Trial (CIRT), testing the effect of methotrexate on cardiovascular outcomes, may also support the use of antiinflammatories to prevent secondary cardiovascular events.(42) It is possible based on the results of the current study that suppression of inflammasome-related…”
ResultMorton, A. C., Rothman, A. M. K., Greenwood, J. P., Gunn, J., Chase, A., Clarke, B., Hall, A. S., Fox, K., Foley, C., Banya, W., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu272 · Cited by 353
Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease
Galea, J., Armstrong, J., Gadsdon, P., Holden, H., Francis, S. E., & Holt, C. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.1000 · Cited by 310
Maier, W., Altwegg, L. A., Corti, R., Gay, S., Hersberger, M., Maly, F. E., Sütsch, G., Roffi, M., Neidhart, M., Eberli, F. R., et al. (2005) · Circulation · doi:10.1161/01.cir.0000158479.58589.0a · Cited by 297
Kato, K., Yonetsu, T., Kim, S.-J., Xing, L., Lee, H., McNulty, I., Yeh, R. W., Sakhuja, R., Zhang, S., Uemura, S., et al. (2012) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.973701 · Cited by 235
Tiret, L., Godefroy, T., Lubos, E., Nicaud, V., Tregouet, D.-A., Barbaux, S., Schnabel, R., Bickel, C., Espinola-Klein, C., Poirier, O., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.519702 · Cited by 229
The role of interleukin‐1 and the inflammasome in gout: Implications for therapy
Pope, R. M., & Tschopp, J. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22938 · Cited by 207
MERHISOUSSI, F., KWAK, B., MAGNE, D., CHADJICHRISTOS, C., BERTI, M., PELLI, G., JAMES, R., MACH, F., & GABAY, C. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.01.008 · Cited by 200
Interleukin‐6 and acute coronary syndrome
Ikeda, U., Ito, T., & Shimada, K. (2001) · Clinical Cardiology · doi:10.1002/clc.4960241103 · Cited by 146
Fisman, E. Z., Benderly, M., Esper, R. J., Behar, S., Boyko, V., Adler, Y., Tanné, D., Matas, Z., & Tenenbaum, A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.045 · Cited by 143
Satoh, M., Tabuchi, T., Itoh, T., & Nakamura, M. (2013) · Clinical Science · doi:10.1042/cs20130043 · Cited by 131
Chamberlain, J., EVANS, D. B., King, A. R., Dewberry, R. M., Dower, S., Crossman, D. C., & Francis, S. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051054 · Cited by 117
Human Vascular Smooth Muscle Cell–Monocyte Interactions and Metalloproteinase Secretion in Culture
Lee, E. Y. P., Grodzinsky, A. J., Libby, P., Clinton, S. K., Lark, M. W., & Lee, R. T. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.12.2284 · Cited by 110
IL-1 signaling in atherosclerosis: sibling rivalry
Sheedy, F. J., & Moore, K. J. (2013) · Nature Immunology · doi:10.1038/ni.2711 · Cited by 70
Nidorf, S. M., Eikelboom, J. W., & Thompson, P. L. (2013) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248413499972 · Cited by 49
Flego, D., Severino, A., Trotta, F., Previtero, M., Ucci, S., Zara, C., Massaro, G., Pedicino, D., Biasucci, L. M., Liuzzo, G., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.01.027 · Cited by 39
Haplotypes of the Caspase-1 Gene, Plasma Caspase-1 Levels, and Cardiovascular Risk
Blankenberg, S., Godefroy, T., Poirier, O., Rupprecht, H. J., Barbaux, S., Bickel, C., Nicaud, V., Schnabel, R. B., Kee, F., Morrison, C. E., et al. (2006) · Circulation Research · doi:10.1161/01.res.0000232324.87983.4b · Cited by 27
Cited by
Ridker, P. M. (2016) · Circulation Research · doi:10.1161/circresaha.115.306656 · Cited by 1,002
Inflammation in atherosclerosis: pathophysiology and mechanisms
Ajoolabady, A., Pratico, D., Lin, L., Mantzoros, C. S., Bahijri, S., Tuomilehto, J., & Ren, J. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-07166-8 · Cited by 447
Colchicine in Patients With Acute Coronary Syndrome: The Australian COPS Randomized Clinical Trial
Tong, D. C., Quinn, S., Nasis, A., Hiew, C., Roberts-Thomson, P., Adams, H., Sriamareswaran, R., Htun, N. M., Wilson, W., Stub, D., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.050771 · Cited by 393
The integration of inflammaging in age-related diseases
Fulop, T., Witkowski, J. M., Olivieri, F., & Larbi, A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.003 · Cited by 348
Martínez, G. J., Celermajer, D. S., & Patel, S. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.12.027 · Cited by 342
Self-citation
Metadata
- Authors
- Martínez, G. J., Robertson, S., Barraclough, J., Xia, Q., Mallat, Z., Bursill, C., Celermajer, D. S., & Patel, S.
- Venue
- Journal of the American Heart Association
- Published
- 2015-08-25
- Volume
- 4
- Issue
- 8
- Pages
- e002128-e002128
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2128383347
- Cited by
- 283
- References
- 47
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.